Authorized by Health Canada
Our first vaccine manufactured in plants is approved.
Our vaccine is only approved in Canada.
Health Canada approved the vaccine on February 24th, 2022. We have several steps to go through before we can make our vaccine available. This overall process will take weeks.
Medicago currently has four vaccine candidates in clinical development.
Check out our R&D program for more information on these four vaccine candidates.
Medicago created a plant-based technology that uses plants as bioreactors to produce non-infectious structures of viruses resembling viruses called virus-like particles (VLP).
VLPs mimic the natural structure of viruses, allowing them to be recognized by the immune system. However, they lack basic genetic material, which makes them non-infectious and incapable of reproducing.
No, Medicago is not publicly traded. It has been privately held since 2013. If you want to learn more about Medicago, follow our journey from the start by watching this video.
Medicago is committed to supporting causes that matter to our employees, our partners, and our communities. Giving back is deeply embedded in Medicago’s culture and is closely aligned with our business purpose. By supporting services, programs and groups that help improve people’s lives, we aim to have a positive impact in our communities.
Donations and Sponsorships Eligibility
Health: organizations that deliver research, diagnosis, treatment and wellness for infectious diseases
Diversity and Inclusion: innovative solutions and initiatives focused on improving different communities’ life and well being
Scientific education: initiatives that help people develop the skills and knowledge in science, immunology or biotechnology
If you have a project which corresponds to our vision and mission, we invite you to contact us. Thank you for your interest in Medicago.
At Medicago, we are united in a common purpose and vision to help create a world better prepared to deal with any disease. Explore opportunities to join #TeamMedicago.
To report a problem with our website, Contact Us.